Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD) (SERRA-I Study)

NCT06991322 is registered in ClinicalTrials.gov with VahatiCor, Inc. as lead sponsor.

NCT NCT06991322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06991322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD) (SERRA-I Study)
Lead sponsor
VahatiCor, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 18, 2025
Completion date
April 30, 2027
Enrollment
30 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronary microvascular disease, coronary microvascular dysfunction